Covasim: an agent-based model of COVID-19 dynamics and interventions CC Kerr, RM Stuart, D Mistry, RG Abeysuriya, G Hart, K Rosenfeld, ... medRxiv, 2020 | 566 | 2020 |
Controlling COVID-19 via test-trace-quarantine CC Kerr, D Mistry, RM Stuart, K Rosenfeld, GR Hart, RC Nunez, ... Nature Communications, 2020 | 100 | 2020 |
Reducing the Carbon Footprint of Academic Conferences: The Example of the American Society of Tropical Medicine and Hygiene T Bousema, P Selvaraj, AA Djimde, D Yakar, B Hagedorn, A Pratt, ... American Journal of Tropical Medicine and Hygiene, 2020 | 69 | 2020 |
Clinical management and mortality among COVID-19 cases in sub-Saharan Africa: a retrospective study from Burkina Faso and simulated case analysis L Skrip, K Derra, M Kaboré, N Noori, A Gansané, I Valéa, H Tinto, ... International Journal of Infectious Diseases 101, 194-200, 2020 | 41 | 2020 |
Estimates of the number and distribution of zero-dose and under-immunised children across remote-rural, urban, and conflict-affected settings in low and middle-income countries A Wigley, J Lorin, D Hogan, CE Utazi, B Hagedorn, E Dansereau, ... PLOS Global Public Health 2 (10), e0001126, 2022 | 28 | 2022 |
Seeding COVID-19 across sub-Saharan Africa: an analysis of reported importation events across 49 countries LA Skrip, P Selvaraj, B Hagedorn, AL Ouédraogo, N Noori, A Orcutt, ... The American Journal of Tropical Medicine and Hygiene 104 (5), 1694, 2021 | 25 | 2021 |
Projection of costs of polio eradication compared to permanent control M Zimmermann, B Hagedorn, H Lyons The Journal of Infectious Diseases 221 (4), 561-565, 2020 | 22 | 2020 |
Optimization of frequency and targeting of measles supplemental immunization activities in Nigeria: a cost-effectiveness analysis M Zimmermann, K Frey, B Hagedorn, AJ Oteri, A Yahya, M Hamisu, ... Vaccine 37 (41), 6039-6047, 2019 | 21 | 2019 |
Assessing the characteristics of un-and under-vaccinated children in low-and middle-income countries: A multi-level cross-sectional study CE Utazi, O Pannell, JMK Aheto, A Wigley, N Tejedor-Garavito, ... PLOS Global Public Health 2 (4), e0000244, 2022 | 17 | 2022 |
Covasim: an agent-based model of COVID-19 dynamics and interventions, 2020 CC Kerr, RM Stuart, D Mistry, RG Abeysuriya, G Hart, K Rosenfeld DOI 10 (2020.05), 10.20097469, 0 | 9 | |
SARS-CoV-2 infection risk during delivery of childhood vaccination campaigns: a modelling study SR Procter, K Abbas, S Flasche, U Griffiths, B Hagedorn, KM O’Reilly, ... BMC medicine 19, 1-12, 2021 | 8 | 2021 |
Cost-effectiveness of using environmental surveillance to target the roll-out typhoid conjugate vaccine BL Hagedorn, J Gauld, N Feasey, H Hu Vaccine 38 (7), 1661-1670, 2020 | 8 | 2020 |
Covasim: an agent-based model of COVID-19 dynamics and interventions. MedRxiv, 2020.05. 10.20097469 CC Kerr, RM Stuart, D Mistry, RG Abeysuriya, G Hart, K Rosenfeld, ... | 7 | 2020 |
The cost saving opportunity of introducing a card review into measles-containing vaccination campaigns BL Hagedorn, A Dabbagh, KA McCarthy Vaccine 37 (41), 6093-6101, 2019 | 7 | 2019 |
Evaluating COVID-19 reporting data in the context of testing strategies across 31 low-and middle-income countries MM Van Gordon, KA McCarthy, JL Proctor, BL Hagedorn International Journal of Infectious Diseases 110, 341-352, 2021 | 5* | 2021 |
Modeling the economic impact of different vial-opening thresholds for measles-containing vaccines PT Wedlock, EA Mitgang, AP Oron, BL Hagedorn, J Leonard, ST Brown, ... Vaccine 37 (17), 2356-2368, 2019 | 4 | 2019 |
Estimates of the cost to build a stand-alone environmental surveillance system for typhoid in low-and middle-income countries B Hagedorn, NA Zhou, CS Fagnant-Sperati, JH Shirai, J Gauld, Y Wang, ... PLOS Global Public Health 3 (1), e0001074, 2023 | 3 | 2023 |
The cost of building an environmental surveillance system for typhoid BL Hagedorn, NA Zhou, CS Fagnant-Sperati, JH Shirai, J Gauld, Y Wang, ... medRxiv, 2021.07. 12.21260395, 2021 | 2 | 2021 |
The effect of regional under-age-5 campaigns on the SARS-CoV2 outbreak in LMIC B Hagedorn, K Frey Institute for Disease Modeling, 2020 | 2* | 2020 |
Estimated Country-Specific Rates of Hospitalized Care for Detected COVID Infections L Skip, B Hagedorn Institute for Disease Modeling, 2020 | 2 | 2020 |